LONDON (Reuters) - British drugmaker GSK sees peak sales of more than $500 million for a drug to treat yeast infections that it licensed from U.S. biotech company Scynexis in a $90 million deal ...

There are plenty of effective solutions, experts say. But first you’ll need an accurate diagnosis. By Alisha Haridasani Gupta Roughly 75 percent of women will deal with the burning, itching and ...

TOKYO (Reuters) - Japanese authorities on Wednesday ordered drugmaker Kobayashi Pharmaceutical to recall three dietary supplement products containing red yeast rice, or beni koji, after they were ...

Women who get lots of painful yeast infections can safely ward them off with a weekly pill, the largest study on the subject has found. Regular, preventive doses of an antifungal drug for six months ...